The board of directors of Livzon Pharmaceutical Group Inc. announced that Mr. Tao Desheng ("Mr. Tao") has ceased to be a member of the remuneration and assessment committee of the Company due to work transfer with effect from 30 December 2021. The other positions held by Mr. Tao in the Group remain unchanged. On 30 December 2021, the Board considered and approved the appointment of Ms. Cui Lijie as a member of the remuneration and assessment committee of the tenth session of the Board, whose tenure commences from the date of passing of the relevant resolution at the Board (that is 30 December 2021) and ends on the expiration of the tenure of the tenth session of the Board.